Microneedle-nanoparticle hybrid platforms for metabolic syndrome: advances in point-of-care diagnostics and transdermal therapeutics.

ABSTRACT: Metabolic syndrome encompasses various conditions, including diabetes, obesity, and metabolic diseases. It is characterized by high blood sugar, abnormal cholesterol, and high blood pressure levels. Research has investigated combined methods using microneedles and nanoparticles for diagnosis and treatment to improve effectiveness while reducing harm to healthy tissues. This process allows potential improvements in diagnostic capabilities for detecting biomarkers associated with metabolic diseases. Using microneedles in conjunction with nanoparticles offers a promising avenue for advancements in metabolic disease management. With the potential for targeted and precise delivery of therapeutic agents, this integrated approach could revolutionize treatment strategies. Combining these technolog

SUBMITTER: Choi J 

PROVIDER: S-EPMC12569312 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature